Enterprise Value

-31.45M

Cash

140.5M

Avg Qtr Burn

-34.18M

Short % of Float

15.46%

Insider Ownership

49.42%

Institutional Own.

43.01%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Posoleucel Details
BK virus, Kidney transplantation

Phase 2

Update

Posoleucel Details
Epstein-Barr virus, Human herpesvirus 6, BK virus, Adenovirus, Cytomegalovirus

Failed

Discontinued

Posoleucel Details
Virus-associated hemorrhagic cystitis , Adenovirus

Failed

Discontinued

ALVR106 Details
Respiratory syncytial virus, Influenza, Human metapneumovirus, Parainfluenza virus

Failed

Discontinued

Failed

Discontinued